Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin to prevent new onset diabetes after kidney transplantation
NCT01683331Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Aug 2012
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin isophane in post-transplant diabetes mellitus (PTDM), sponsored by University of Michigan. Started Aug 2012; status: completed.
02
Drugs
insulin isophane
03
Conditions
post-transplant diabetes mellitus (PTDM)
Beyond the preview
Go deeper on NCT01683331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683331.